Eiger BioPharmaceuticals, Inc. (EIGR)

NASDAQ: EIGR · IEX Real-Time Price · USD
7.02
-0.37 (-5.01%)
At close: Oct 5, 2022 4:00 PM
7.03
+0.01 (0.14%)
Pre-market: Oct 5, 2022 7:51 PM EDT

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011
Net Income
-33.92-65.05-70.25-52.39-42.45-47.09-13.32-1.52-20-15.72
Upgrade
Depreciation & Amortization
0.80.650.490.050.040.020.010.010.070.06
Upgrade
Share-Based Compensation
7.95.975.685.014.243.190.230.031.390.3
Upgrade
Other Operating Activities
-46.13-4.750.474.66-0.215.93.950.22.340.72
Upgrade
Operating Cash Flow
-71.34-63.19-63.61-42.67-38.37-37.97-9.13-1.28-16.2-14.64
Upgrade
Capital Expenditures
0.06-0.26-0.48-0.14-0.04-0.06-0.05-0-0.09-0.05
Upgrade
Acquisitions
0000028.020000
Upgrade
Change in Investments
14.98-44.53-16-28.9422.5-32.150010.94-21.79
Upgrade
Other Investing Activities
46.490000.200000
Upgrade
Investing Cash Flow
61.53-44.79-16.47-29.0922.66-4.19-0.05-010.85-21.83
Upgrade
Share Issuance / Repurchase
3.396.9753.3290.7419.9450.3400-1.694.81
Upgrade
Debt Issued / Paid
-0.1804.059.94014.765.9801.1-0.11
Upgrade
Other Financing Activities
0.050.50.830.310.050.047.21.92045.14
Upgrade
Financing Cash Flow
3.1797.4658.2100.9819.9965.1413.181.92-0.649.84
Upgrade
Net Cash Flow
-6.64-10.51-21.8929.234.2822.9840.63-5.9413.37
Upgrade
Free Cash Flow
-71.29-63.44-64.09-42.81-38.42-38.03-9.18-1.28-16.28-14.69
Upgrade
Free Cash Flow Margin
-587.10%---------
Upgrade
Free Cash Flow Per Share
-2.10-2.25-2.81-3.14-4.40-6.33-42.85-6.62-276.24-267.98
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).